Literature DB >> 16755380

Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability.

F A Zucca1, C Bellei, S Giannelli, M R Terreni, M Gallorini, E Rizzio, G Pezzoli, A Albertini, L Zecca.   

Abstract

In this study a comparative analysis of iron molecules during aging was performed in locus coeruleus (LC) and substantia nigra (SN), known targets of Parkinson's Disease (PD) and related disorders. LC and SN neurons, especially the SN pars compacta, degenerate in PD and other forms of parkinsonism. Iron and its major molecular forms, such as ferritin and neuromelanin (NM), were measured in LC and SN of normal subjects at various ages. Iron levels were lower, H-ferritin/iron ratio was higher and the iron content in NM was lower in LC than in SN. Iron deposits were abundant in SN tissue, very scarse in LC tissue and completely absent in pigmented neurons of both SN and LC. In both regions H- and L-ferritins were present only in glia. This suggests that in LC neurons iron mobilization and toxicity is lower than that in SN and is efficiently buffered by NM. Ferritins accomplish the same buffering function in glial cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16755380     DOI: 10.1007/s00702-006-0453-2

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  47 in total

1.  Disease-specific patterns of locus coeruleus cell loss.

Authors:  D C German; K F Manaye; C L White; D J Woodward; D D McIntire; W K Smith; R N Kalaria; D M Mann
Journal:  Ann Neurol       Date:  1992-11       Impact factor: 10.422

2.  Noradrenergic mechanisms in age-related cognitive decline.

Authors:  A F Arnsten; P S Goldman-Rakic
Journal:  J Neural Transm Suppl       Date:  1987

3.  Chronic manganese intoxication.

Authors:  D G Cook; S Fahn; K A Brait
Journal:  Arch Neurol       Date:  1974-01

4.  Image analyser-assisted morphometry of the locus coeruleus in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.

Authors:  W J Hoogendijk; C W Pool; D Troost; E van Zwieten; D F Swaab
Journal:  Brain       Date:  1995-02       Impact factor: 13.501

5.  On the origin and significance of neuromelanin.

Authors:  D G Graham
Journal:  Arch Pathol Lab Med       Date:  1979-07       Impact factor: 5.534

Review 6.  The neuromelanin of human substantia nigra and its interaction with metals.

Authors:  L Zecca; D Tampellini; A Gatti; R Crippa; M Eisner; D Sulzer; S Ito; R Fariello; M Gallorini
Journal:  J Neural Transm (Vienna)       Date:  2002-05       Impact factor: 3.575

7.  Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain.

Authors:  E Sofic; P Riederer; H Heinsen; H Beckmann; G P Reynolds; G Hebenstreit; M B Youdim
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

8.  Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.

Authors:  E Hirsch; A M Graybiel; Y A Agid
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

Review 9.  Neurodegenerative diseases and oxidative stress.

Authors:  Kevin J Barnham; Colin L Masters; Ashley I Bush
Journal:  Nat Rev Drug Discov       Date:  2004-03       Impact factor: 84.694

Review 10.  Epidemiology of Parkinson's disease.

Authors:  C M Tanner; S M Goldman
Journal:  Neurol Clin       Date:  1996-05       Impact factor: 3.806

View more
  38 in total

1.  Quantitative magnetization transfer imaging of the human locus coeruleus.

Authors:  Paula Trujillo; Kalen J Petersen; Matthew J Cronin; Ya-Chen Lin; Hakmook Kang; Manus J Donahue; Seth A Smith; Daniel O Claassen
Journal:  Neuroimage       Date:  2019-06-21       Impact factor: 6.556

2.  Single-Cell Approaches for Studying the Role of Mitochondrial DNA in Neurodegenerative Disease.

Authors:  Laura J Bailey; Joanna L Elson; Ilse S Pienaar
Journal:  Methods Mol Biol       Date:  2021

Review 3.  Neuromelanin of the human substantia nigra: an update.

Authors:  Fabio A Zucca; Emy Basso; Francesca A Cupaioli; Emanuele Ferrari; David Sulzer; Luigi Casella; Luigi Zecca
Journal:  Neurotox Res       Date:  2013-10-24       Impact factor: 3.911

Review 4.  Age-related variability in decision-making: Insights from neurochemistry.

Authors:  Anne S Berry; William J Jagust; Ming Hsu
Journal:  Cogn Affect Behav Neurosci       Date:  2019-06       Impact factor: 3.282

5.  Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders.

Authors:  Niels Bergsland; Eleonora Tavazzi; Ferdinand Schweser; Dejan Jakimovski; Jesper Hagemeier; Michael G Dwyer; Robert Zivadinov
Journal:  CNS Drugs       Date:  2019-11       Impact factor: 5.749

6.  A reappraisal of Fe(III) adsorption by melanin.

Authors:  Rhiannon Lee Schroeder; Jacobus Petrus Gerber
Journal:  J Neural Transm (Vienna)       Date:  2014-05-21       Impact factor: 3.575

Review 7.  The role of iron in brain ageing and neurodegenerative disorders.

Authors:  Roberta J Ward; Fabio A Zucca; Jeff H Duyn; Robert R Crichton; Luigi Zecca
Journal:  Lancet Neurol       Date:  2014-10       Impact factor: 44.182

8.  Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease.

Authors:  Fabio A Zucca; Renzo Vanna; Francesca A Cupaioli; Chiara Bellei; Antonella De Palma; Dario Di Silvestre; Pierluigi Mauri; Sara Grassi; Alessandro Prinetti; Luigi Casella; David Sulzer; Luigi Zecca
Journal:  NPJ Parkinsons Dis       Date:  2018-06-05

Review 9.  Locus Coeruleus Modulates Neuroinflammation in Parkinsonism and Dementia.

Authors:  Filippo Sean Giorgi; Francesca Biagioni; Alessandro Galgani; Nicola Pavese; Gloria Lazzeri; Francesco Fornai
Journal:  Int J Mol Sci       Date:  2020-11-16       Impact factor: 5.923

10.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.